SpOvum has recently announced the launch of its advanced AI-powered platform, SpOvum ARTPT, aimed at advancing patient interaction in the field of Assisted Reproductive Technology (ART). As per the statement, the ARTGPT leverages natural language processing (NLP) to provide patients with instant, conversational responses 24/7, ensuring continuous support outside clinic hours. The platform offers personalised information based on individual ART-related concerns, drawing from reliable, indexed medical guides to provide fact-based, tailored answers. This is reportedly the first time the deep tech startup has ventured into the B2C domain with its products.
The SpOvum ARTGPT enhances accessibility across India by supporting multiple regional languages, including Hindi, Kannada, Tamil, Telugu, Bengali, and many more, fostering inclusivity for a diverse user base. Its design allows users to access information on any device, ensuring that help is always within reach.
During the launch, Dr Ramnath Babu, CEO and Co-Founder, of SpOvum Technologies said “We are thrilled to introduce ARTGPT, the first AI platform of its kind in India’s health tech sector, offering round-the-clock, personalised support for patients. Our ARTGPT pulls information from guides and other reliable ART/infertility documents when asked questions by the users and provides only relevant information. If the query is incorrect or there is no relatable information to be shared, then the product has been designed to not provide any misinformation.”
“By integrating multilingual capabilities and simplifying complex medical information, SpOvum ARTGPT enhances accessibility and empowers patients to make informed decisions about their reproductive health. It also provides consistent, factual information, strengthening trust between patients and healthcare providers. Apart from this, the patient interactions and data are secure and confidential,” added Dr Santosh Bhargav DB, CTO and Co-founder of SpOvum Technologies.
SpOvum Technologies through the implementation of ARTGPT currently is striving to reach as many people as possible. In the coming days, the startup aims to integrate this with the currently existing A.R.T Dashboard and even phone applications where patient data is in synch with the GPT and information is tailored to respective users, inclusive of daily tracking of medicine intake, ovulations, and other health metrics.